Literature DB >> 20842580

Treatment of acute migraine in the pediatric population.

Hope L O'Brien1, Marielle A Kabbouche, Andrew D Hershey.   

Abstract

OPINION STATEMENT: The recognition of the diagnosis of migraine in the pediatric population is increasing. Early and aggressive treatment of migraine in children and adolescents with the use of over-the-counter medications has proven effective. In addition, the off-label use of many migraine-specific medications is often accepted in the absence of sufficient evidence-based trials. Mild to severe cases of migraine should be treated with NSAIDs, with triptans used for moderate to severe headaches that are unresponsive to over-the-counter therapy. Rescue medication including dihydroergotamine (DHE) should be used for intractable migraines, preferably in the hospital setting. In patients with associated symptoms of nausea and vomiting, antiemetics with antidopaminergic properties can be helpful through their action on central migraine generation. Furthermore, patients and families should be educated about nonpharmacologic aspects of management such as preventing episodic migraine through lifestyle modification and avoidance of triggers.

Entities:  

Year:  2010        PMID: 20842580     DOI: 10.1007/s11940-010-0069-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  22 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Efficacy of zolmitriptan nasal spray in adolescent migraine.

Authors:  Donald W Lewis; Paul Winner; Andrew D Hershey; Warren W Wasiewski
Journal:  Pediatrics       Date:  2007-08       Impact factor: 7.124

3.  A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents.

Authors:  P Winner; A D Rothner; J Saper; R Nett; M Asgharnejad; A Laurenza; R Austin; M Peykamian
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

Review 4.  Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

Authors:  D Lewis; S Ashwal; A Hershey; D Hirtz; M Yonker; S Silberstein
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

5.  Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.

Authors:  Steven L Linder; Ninan T Mathew; Roger K Cady; Gary Finlayson; Gary Ishkanian; Donald W Lewis
Journal:  Headache       Date:  2008-05-14       Impact factor: 5.887

6.  Inpatient treatment of status migraine with dihydroergotamine in children and adolescents.

Authors:  Marielle A Kabbouche; Scott W Powers; Ann Segers; Susan LeCates; Paula Manning; Shannon Biederman; Polly Vaughan; Danny Burdine; Andrew D Hershey
Journal:  Headache       Date:  2009-01       Impact factor: 5.887

7.  Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac.

Authors:  David C Brousseau; Susan J Duffy; Angela C Anderson; James G Linakis
Journal:  Ann Emerg Med       Date:  2004-02       Impact factor: 5.721

8.  Children's ibuprofen suspension for the acute treatment of pediatric migraine.

Authors:  Donald W Lewis; David Kellstein; Georg Dahl; Bonnie Burke; L M Frank; S Toor; R S Northam; L W White; L Lawson
Journal:  Headache       Date:  2002-09       Impact factor: 5.887

9.  Emergency department management of acute migraine in children in Canada: a practice variation study.

Authors:  Lawrence Richer; Lee Graham; Terry Klassen; Brian Rowe
Journal:  Headache       Date:  2007-05       Impact factor: 5.887

10.  Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache.

Authors:  M Coppola; D M Yealy; R A Leibold
Journal:  Ann Emerg Med       Date:  1995-11       Impact factor: 5.721

View more
  4 in total

Review 1.  Migraine and epilepsy in the pediatric population.

Authors:  Christopher B Oakley; Eric H Kossoff
Journal:  Curr Pain Headache Rep       Date:  2014-03

2.  Treatment of pediatric migraine.

Authors:  Hope L O'Brien; Marielle A Kabbouche; Joanne Kacperski; Andrew D Hershey
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

Review 3.  Breastfeeding and migraine drugs.

Authors:  Riccardo Davanzo; Jenny Bua; Giulia Paloni; Giulia Facchina
Journal:  Eur J Clin Pharmacol       Date:  2014-09-13       Impact factor: 2.953

Review 4.  Optimal management of severe nausea and vomiting in migraine: improving patient outcomes.

Authors:  Miguel Ja Láinez; Ana García-Casado; Francisco Gascón
Journal:  Patient Relat Outcome Meas       Date:  2013-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.